Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1980-10-21
1986-08-19
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514218, 544291, A61K 31505, C07D40304
Patent
active
046070346
ABSTRACT:
There are presented novel quinazoline derivatives, namely 2-(4-substituted-carbamoyl-piperazin-1-yl)quinazoline derivatives, 2-(4-substituted-carbamoyl-homopiperazin-1-yl)quinazoline derivatives, 2-(4-substituted-thiocarbamoyl-piperazin-1-yl)quinazoline derivatives and 2-(4-substituted-thiocarbamoyl-piperazin-1-yl)quinazoline derivatives, having excellent antihypertensive activities.
REFERENCES:
patent: 3635979 (1972-01-01), Hess
patent: 4001237 (1977-01-01), Partyka et al.
patent: 4062844 (1977-12-01), Hammen
patent: 4243666 (1981-01-01), Campbell et al.
patent: 4287341 (1981-09-01), Hess et al.
Sekiya et al., Pyrimidine derivatives 1. Eur. J. Med. Chem.--Chimica Therapeutica, Jul.-Aug. 1980-15, No. 4, pp. 317-322.
Hanazuka Mitsuo
Hiranuma Hidetoshi
Mizogami Susumu
Sekiya Tetsuo
Hollrah Glennon H.
Mitsubishi Yuka Pharmaceutical Co., Ltd.
Turnipseed James H.
LandOfFree
Quinazoline derivatives and pharmaceutical composition thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinazoline derivatives and pharmaceutical composition thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinazoline derivatives and pharmaceutical composition thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-394108